Biotechnology VALUE FUND L P, 10% Owner at Cullinan Oncology, Inc. (CGEM), bought 751,396 shares at $11.00 ($8.3M) on 2022-06-01, disclosed to the SEC on 2022-06-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.00 | 44,746 | $492K | 6.0% |
| 2 | $11.00 | 301,009 | $3.3M | 40.1% |
| 3 | $11.00 | 405,641 | $4.5M | 54.0% |
| Total | $11.00 avg | 751,396 | $8.3M | 100% |
| Filing → |
| OLMA | BUY | 2021-12-02 | $13.9M | — | Filing → |
| KYMR | BUY | 2021-07-06 | $25.6M | — | Filing → |
| RAIN | BUY | 2021-07-06 | $15.7M | — | Filing → |